Apricus Biosciences’ Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom

SAN DIEGO and ZURICH, Switzerland, Sept. 13, 2012 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (Nasdaq:APRI) and Takeda Pharmaceuticals International GmbH jointly announced today that they have entered into an exclusive license agreement to market Vitaros(R), …

Related Post
بليسانتون، كاليفورنيا ( Marketwired / Asianet-Pakistan – 25 يونيو 2013)– أعلنت اليوم شركة Callidus Software
LONDON–(Marketwire / Asianet-Pakistan – March 20, 2013) – Following the success of its recent iPhone(tm)
HOUSTON, March 19, 2013 /PRNewswire / Asianet-Pakistan — Baker Botts L.L.P. partner David Sterling has

Leave a Reply

Your email address will not be published. Required fields are marked *